{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T22:51:02Z","timestamp":1787698262114,"version":"build-2784847793"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,6,21]],"date-time":"2014-06-21T00:00:00Z","timestamp":1403308800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Complement Altern Med"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1472-6882-14-198","type":"journal-article","created":{"date-parts":[[2014,6,21]],"date-time":"2014-06-21T17:02:53Z","timestamp":1403370173000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Increasing effect of Tangzhiqing formula on IRS-1-dependent PI3K\/AKT signaling in muscle"],"prefix":"10.1186","volume":"14","author":[{"given":"Jing","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yating","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuefeng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanlin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,6,21]]},"reference":[{"issue":"Suppl 2","key":"1794_CR1","doi-asserted-by":"publisher","first-page":"S157","DOI":"10.2337\/dc09-S302","volume":"32","author":"RA DeFronzo","year":"2009","unstructured":"DeFronzo RA, Tripathy D: Skeletal muscle insulin resistance is the primary defect in type 2 diabetes. Diabetes Care. 2009, 32 (Suppl 2): S157-S163.","journal-title":"Diabetes Care"},{"issue":"1","key":"1794_CR2","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1017\/S0029665110003915","volume":"70","author":"DG Hardie","year":"2010","unstructured":"Hardie DG: Energy sensing by the AMP-activated protein kinase and its effects on muscle metabolism. Proc Nutr Soc. 2010, 70 (1): 92-99.","journal-title":"Proc Nutr Soc"},{"issue":"4","key":"1794_CR3","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1177\/153537020122600404","volume":"226","author":"RV Farese","year":"2001","unstructured":"Farese RV: Insulin-sensitive phospholipid signaling systems and glucose transport. Update II. Exp Biol Med (Maywood). 2001, 226 (4): 283-295.","journal-title":"Exp Biol Med (Maywood)"},{"issue":"4","key":"1794_CR4","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.biopha.2008.01.009","volume":"62","author":"K Maiese","year":"2008","unstructured":"Maiese K: Triple play: promoting neurovascular longevity with nicotinamide, WNT, and erythropoietin in diabetes mellitus. Biomed Pharmacother. 2008, 62 (4): 218-232.","journal-title":"Biomed Pharmacother"},{"issue":"7","key":"1794_CR5","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1249\/01.MSS.0000132387.25853.3B","volume":"36","author":"A Krook","year":"2004","unstructured":"Krook A, Wallberg-Henriksson H, Zierath JR: Sending the signal: molecular mechanisms regulating glucose uptake. Med Sci Sports Exerc. 2004, 36 (7): 1212-1217.","journal-title":"Med Sci Sports Exerc"},{"issue":"1","key":"1794_CR6","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1042\/BJ20081673","volume":"419","author":"LM Ooms","year":"2009","unstructured":"Ooms LM, Horan KA, Rahman P, Seaton G, Gurung R, Kethesparan DS, Mitchell CA: The role of the inositol polyphosphate 5-phosphatases in cellular function and human disease. Biochem J. 2009, 419 (1): 29-49.","journal-title":"Biochem J"},{"key":"1794_CR7","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1111\/j.1749-6632.2012.06725.x","volume":"1271","author":"JY Lee","year":"2012","unstructured":"Lee JY, Kim YR, Park J, Kim S: Inositol polyphosphate multikinase signaling in the regulation of metabolism. Ann N Y Acad Sci. 2012, 1271: 68-74.","journal-title":"Ann N Y Acad Sci"},{"issue":"5","key":"1794_CR8","doi-asserted-by":"publisher","first-page":"253","DOI":"10.5732\/cjc.013.10057","volume":"32","author":"KH Khan","year":"2013","unstructured":"Khan KH, Yap TA, Yan L, Cunningham D: Targeting the PI3K-AKT-mTOR signaling network in cancer. Chin J Cancer. 2013, 32 (5): 253-265.","journal-title":"Chin J Cancer"},{"issue":"9","key":"1794_CR9","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1177\/153537020523000901","volume":"230","author":"RV Farese","year":"2005","unstructured":"Farese RV, Sajan MP, Standaert ML: Insulin-sensitive protein kinases (atypical protein kinase C and protein kinase B\/Akt): actions and defects in obesity and type II diabetes. Exp Biol Med (Maywood). 2005, 230 (9): 593-605.","journal-title":"Exp Biol Med (Maywood)"},{"issue":"3","key":"1794_CR10","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1038\/nri2036","volume":"7","author":"C Rommel","year":"2007","unstructured":"Rommel C, Camps M, Ji H: PI3K delta and PI3K gamma: partners in crime in inflammation in rheumatoid arthritis and beyond?. Nat Rev Immunol. 2007, 7 (3): 191-201.","journal-title":"Nat Rev Immunol"},{"issue":"3","key":"1794_CR11","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.jep.2010.01.044","volume":"128","author":"W Tao","year":"2010","unstructured":"Tao W, Deqin Z, Yuhong L, Hong L, Zhanbiao L, Chunfeng Z, Limin H, Xiumei G: Regulation effects on abnormal glucose and lipid metabolism of TZQ-F, a new kind of Traditional Chinese Medicine. J Ethnopharmacol. 2010, 128 (3): 575-582.","journal-title":"J Ethnopharmacol"},{"issue":"4","key":"1794_CR12","first-page":"58","volume":"19","author":"YT An","year":"2013","unstructured":"An YT, Liu XF, Qian Q, Zhang DQ, Li YH, Gao XM, Zhang Y, Wang T: Triglyceride accumulation: inhibitory effects of Tangzhiqing formula. Altern Ther Health M. 2013, 19 (4): 58-69.","journal-title":"Altern Ther Health M"},{"key":"1794_CR13","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1472-6823-11-16","volume":"11","author":"AM Thompson","year":"2011","unstructured":"Thompson AM, Zhang Y, Tong W, Xu T, Chen J, Zhao L, Kelly TN, Chen CS, Bazzano LA, He J: Association of inflammation and endothelial dysfunction with metabolic syndrome, prediabetes and diabetes in adults from Inner Mongolia, China. BMC Endocr Disord. 2011, 11: 16-","journal-title":"BMC Endocr Disord"},{"issue":"4","key":"1794_CR14","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1515\/JBCPP.1997.8.4.223","volume":"8","author":"HK Ortmeyer","year":"1997","unstructured":"Ortmeyer HK: Insulin decreases skeletal muscle cAMP-dependent protein kinase (PKA) activity in normal monkeys and increases PKA activity in insulin-resistant rhesus monkeys. J Basic Clin Physiol Pharmacol. 1997, 8 (4): 223-235.","journal-title":"J Basic Clin Physiol Pharmacol"},{"issue":"10","key":"1794_CR15","doi-asserted-by":"publisher","first-page":"2936","DOI":"10.2337\/diabetes.51.10.2936","volume":"51","author":"ML Standaert","year":"2002","unstructured":"Standaert ML, Ortmeyer HK, Sajan MP, Kanoh Y, Bandyopadhyay G, Hansen BC, Farese RV: Skeletal muscle insulin resistance in obesity-associated type 2 diabetes in monkeys is linked to a defect in insulin activation of protein kinase C-zeta\/lambda\/iota. Diabetes. 2002, 51 (10): 2936-2943.","journal-title":"Diabetes"},{"issue":"11","key":"1794_CR16","doi-asserted-by":"publisher","first-page":"2598","DOI":"10.2337\/diabetes.50.11.2598","volume":"50","author":"C Yang","year":"2001","unstructured":"Yang C, Chang TJ, Chang JC, Liu MW, Tai TY, Hsu WH, Chuang LM: Rosiglitazone (BRL 49653) enhances insulin secretory response via phosphatidylinositol 3-kinase pathway. Diabetes. 2001, 50 (11): 2598-2602.","journal-title":"Diabetes"},{"issue":"1","key":"1794_CR17","doi-asserted-by":"publisher","first-page":"43","DOI":"10.2337\/diabetes.52.1.43","volume":"52","author":"NG Patel","year":"2003","unstructured":"Patel NG, Holder JC, Smith SA, Kumar S, Eggo MC: Differential regulation of lipogenesis and leptin production by independent signaling pathways and rosiglitazone during human adipocyte differentiation. Diabetes. 2003, 52 (1): 43-50.","journal-title":"Diabetes"},{"issue":"1","key":"1794_CR18","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.metabol.2008.08.013","volume":"58","author":"WJ Kong","year":"2009","unstructured":"Kong WJ, Zhang H, Song DQ, Xue R, Zhao W, Wei J, Wang YM, Shan N, Zhou ZX, Yang P, You XF, Li ZR, Si SY, Zhao LX, Pan HN, Jiang JD: Berberine reduces insulin resistance through protein kinase C-dependent up-regulation of insulin receptor expression. Metabolism. 2009, 58 (1): 109-119.","journal-title":"Metabolism"},{"issue":"22","key":"1794_CR19","doi-asserted-by":"publisher","first-page":"3748","DOI":"10.2174\/092986712801661130","volume":"19","author":"DA Altomare","year":"2012","unstructured":"Altomare DA, Khaled AR: Homeostasis and the importance for a balance between AKT\/mTOR activity and intracellular signaling. Curr Med Chem. 2012, 19 (22): 3748-3762.","journal-title":"Curr Med Chem"},{"issue":"1","key":"1794_CR20","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1006\/bbrc.1994.2738","volume":"205","author":"H Konishi","year":"1994","unstructured":"Konishi H, Shinomura T, Kuroda S, Ono Y, Kikkawa U: Molecular cloning of rat RAC protein kinase alpha and beta and their association with protein kinase C zeta. Biochem Biophys Res Commun. 1994, 205 (1): 817-825.","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"1794_CR21","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1089\/ars.2010.3234","volume":"14","author":"HK Ortmeyer","year":"2010","unstructured":"Ortmeyer HK, Sajan MP, Miura A, Kanoh Y, Rivas J, Li Y, Standaert ML, Ryan AS, Bodkin NL, Farese RV, Hansen BC: Insulin signaling and insulin sensitizing in muscle and liver of obese monkeys: peroxisome proliferator-activated receptor gamma agonist improves defective activation of atypical protein kinase C. Antioxid Redox Signal. 2010, 14 (2): 207-219.","journal-title":"Antioxid Redox Signal"},{"issue":"24","key":"1794_CR22","doi-asserted-by":"publisher","first-page":"24929","DOI":"10.1074\/jbc.M402440200","volume":"279","author":"ML Standaert","year":"2004","unstructured":"Standaert ML, Sajan MP, Miura A, Kanoh Y, Chen HC, Farese RV, Farese RV: Insulin-induced activation of atypical protein kinase C, but not protein kinase B, is maintained in diabetic (ob\/ob and Goto-Kakazaki) liver. Contrasting insulin signaling patterns in liver versus muscle define phenotypes of type 2 diabetic and high fat-induced insulin-resistant states. J Biol Chem. 2004, 279 (24): 24929-24934.","journal-title":"J Biol Chem"},{"issue":"50","key":"1794_CR23","doi-asserted-by":"publisher","first-page":"6473","DOI":"10.1038\/onc.2008.313","volume":"27","author":"TF Franke","year":"2008","unstructured":"Franke TF: PI3K\/Akt: getting it right matters. Oncogene. 2008, 27 (50): 6473-6488.","journal-title":"Oncogene"},{"issue":"1","key":"1794_CR24","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1172\/JCI10294","volume":"108","author":"JK Kim","year":"2001","unstructured":"Kim JK, Zisman A, Fillmore JJ, Peroni OD, Kotani K, Perret P, Zong H, Dong J, Kahn CR, Kahn BB, Shulman GI: Glucose toxicity and the development of diabetes in mice with muscle-specific inactivation of GLUT4. J Clin Invest. 2001, 108 (1): 153-160.","journal-title":"J Clin Invest"}],"container-title":["BMC Complementary and Alternative Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1472-6882-14-198.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1472-6882-14-198\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1472-6882-14-198","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1472-6882-14-198.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T04:44:53Z","timestamp":1630557893000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccomplementalternmed.biomedcentral.com\/articles\/10.1186\/1472-6882-14-198"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6,21]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["1794"],"URL":"https:\/\/doi.org\/10.1186\/1472-6882-14-198","relation":{},"ISSN":["1472-6882"],"issn-type":[{"value":"1472-6882","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,6,21]]},"assertion":[{"value":"6 November 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 June 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"198"}}